trueFY0001820931--12-31CAUnits,each consisting of one Class A ordinary share, $0.0001 par value, and one-fourth of one redeemable warrant...
Alvotech est une plateforme de biosimilaires de premier plan, axée sur le développement et la fabrication de médicaments biosimilaires de haute...
Alvotech ist eine führende Biosimilar-Plattform mit Fokus auf der Entwicklung und Herstellung hochwertiger Biosimilar-Medikamente für globale...
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fourth of one redeemable warrant Warrants included as part of...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC...
false 0001820931 0001820931 2021-12-07 2021-12-07 0001820931 us-gaap:CapitalUnitsMember 2021-12-07 2021-12-07 0001820931 us-gaap:WarrantMember...
Alvotech is a leading pure play biosimilar platform focused on the development and manufacture of high-quality biosimilar medicines for global...
falseQ3Oaktree Acquisition Corp. II0001820931--12-31CA36.1 0001820931 2021-01-01 2021-09-30 0001820931 2021-09-30 0001820931 2020-12-31...
falseQ2Oaktree Acquisition Corp. II0001820931--12-31CAP5Y36.1 0001820931 2021-01-01 2021-06-30 0001820931 2020-12-31 0001820931 2021-06-30...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.